Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive Cpsulitis
HVLA-MET-AC
COMPARATIVE EFFECTS OF HIGH-VELOCITY LOW-AMPLITUDE (HVLA) THRUST AND MUSCLE ENERGY TECHNIQUE (MET) ON SHOULDER MOBILITY AND PAIN IN PATIENTS WITH ADHESIVE CAPSULITIS
1 other identifier
interventional
66
1 country
1
Brief Summary
This study compared the effects of High-Velocity Low-Amplitude (HVLA) thrust and Post-Isometric Relaxation Muscle Energy Technique (PIR-MET) on pain and shoulder mobility in patients with adhesive capsulitis. Sixty-six participants received either HVLA or PIR-MET with conventional physiotherapy for four weeks. Both treatments improved pain and range of motion, but PIR-MET showed significantly greater improvement, making it a more effective approach for managing frozen shoulder symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2026
CompletedFirst Submitted
Initial submission to the registry
May 14, 2026
CompletedFirst Posted
Study publicly available on registry
May 20, 2026
CompletedMay 20, 2026
May 1, 2026
6 months
May 14, 2026
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS) for Pain
Pain intensity was assessed using the Visual Analogue Scale (VAS), a 10 cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Participants marked their perceived shoulder pain level before and after the four-week intervention period.
Baseline and after 4 weeks of intervention
Study Arms (2)
Group A- HVLA Thrust
EXPERIMENTALParticipants in this group received high velocity, low amplitude thrust manipulation to the glenohumeral joint. Treatment was delivered by a trained physical therapist. The intervention aimed to restore joint mobility and reduce pain in patients diagnosed with adhesive capsulitis. Sessions were conducted 3 times per week for 12 weeks, in addition to a standardized home exercise program.
Group-B MET
EXPERIMENTALParticipants in this group received muscle energy technique applied to the shoulder muscles to improve range of motion and decrease pain. The technique involved active contraction of the patient against manual resistance followed by stretching. Sessions were conducted 3 times per week for 12 weeks, in addition to a standardized home exercise program.
Interventions
A manual therapy technique involving a quick, controlled thrust applied to the glenohumeral joint at the end of the available range of motion. The goal is to improve joint play and mobility. Each session lasted approximately 10-15 minutes. The intervention was performed 3 times per week for 12 weeks. Adverse events were monitored throughout the study.
An active manual therapy technique where the patient contracts the shoulder muscles against the therapist's resistance, followed by a passive stretch. Target muscles included the posterior capsule, pectoralis major, and rotator cuff as indicated. Each session lasted approximately 15-20 minutes. The intervention was performed 3 times per week for 12 weeks.
Eligibility Criteria
You may qualify if:
- Participants diagnosed with Stage II or III Adhesive Capsulitis Age between 40 and 65 years Both male and female participants Presence of shoulder pain and restricted range of motion for at least 3 months Limitation of active and passive shoulder movements, particularly external rotation Willingness to participate and provide informed consent Ability to attend treatment sessions for four weeks
You may not qualify if:
- History of shoulder fracture, dislocation, or recent trauma Previous shoulder surgery Neurological disorders affecting shoulder function Rheumatoid arthritis or other systemic inflammatory conditions Cervical radiculopathy or referred pain from the cervical spine Rotator cuff tear or severe shoulder instability Malignancy or infection involving the shoulder joint Participants receiving other concurrent shoulder treatments Contraindications to manual therapy or physiotherapy interventions Unwillingness to participate or inability to complete the treatment protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Principal Investigator
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- This study was single-blinded. Participants were unaware of their treatment group allocation throughout the intervention period to minimize performance and response bias. Care providers and investigators administering the interventions were not blinded due to the nature of the manual therapy techniques.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal InvestigatorG
Study Record Dates
First Submitted
May 14, 2026
First Posted
May 20, 2026
Study Start
November 9, 2025
Primary Completion
April 29, 2026
Study Completion
May 6, 2026
Last Updated
May 20, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- It will be available after the completion of study
- Access Criteria
- De-identified participant data, including demographic details, pain scores, shoulder range-of-motion data, study protocol, and analysis information, will be available to qualified researchers upon reasonable request and approval. Access will be provided through secure electronic sharing while maintaining participant confidentiality and ethical standards.
Only IPD used in the result publication will be shared